awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q28570898-36C372BB-F77A-4794-8EC0-01E33C841C41
Q28570898-36C372BB-F77A-4794-8EC0-01E33C841C41
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28570898-36C372BB-F77A-4794-8EC0-01E33C841C41
RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFalpha or anti-IL-1 therapies
P2860
Q28570898-36C372BB-F77A-4794-8EC0-01E33C841C41
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28570898-36C372BB-F77A-4794-8EC0-01E33C841C41
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
542081fc4f4db463f243493316791c766c39f4d1
P2860
The receptor activator of nuclear factor (NF)-kappaB ligand (RANKL) is a new chemotactic factor for human monocytes.